BioCardia Newsroom

BioCardia Analyst Ratings

BenzingaNov 15 02:24

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

BenzingaNov 15 02:24

BioCardia's Strong Q3 Performance and Strategic Trials Drive Buy Rating

TipRanksNov 14 19:19

BioCardia Analyst Ratings

BenzingaOct 28 23:17

H.C. Wainwright Maintains BioCardia(BCDA.US) With Buy Rating, Raises Target Price to $25

Futu NewsAug 22 21:31

Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and CytomX Therapeutics (CTMX)

TipRanksAug 22 21:22

BioCardia Analyst Ratings

BenzingaAug 22 01:34

HC Wainwright & Co. Maintains Buy on BioCardia, Adjusts Price Target To $25 (1-15 Reverse Stock Split)

BenzingaAug 17 01:54

BioCardia Analyst Ratings

BenzingaAug 17 01:50

BioCardia Analyst Ratings

BenzingaJul 26 19:50

H.C. Wainwright Maintains BioCardia(BCDA.US) With Buy Rating, Cuts Target Price to $4

Futu NewsJul 26 18:33

HC Wainwright & Co. : The BioCardia (BCDA.US) rating was reaffirmed, adjusted from buy to buy rating, and the target price was adjusted from $4.00 to $4.00.

Zhitong FinanceMay 30 01:31

BioCardia Analyst Ratings

BenzingaMay 30 01:30

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $4 Price Target

BenzingaMay 30 01:30

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $4 Price Target

BenzingaNov 15, 2023 00:22

BioCardia Analyst Ratings

BenzingaNov 15, 2023 00:20

Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and Femasys (FEMY)

TipRanksNov 14, 2023 23:40

BioCardia's Strategic Clinical Advancements and Potential Growth Opportunities Prompt Buy Rating

TipRanksNov 9, 2023 19:51

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $4 Price Target

BenzingaOct 12, 2023 00:35

BioCardia Analyst Ratings

BenzingaOct 12, 2023 00:33